Administrative Core supports MGNet's work on myasthenia gravis
Official title: Administrative Core
Funded at George Washington University · NIH-11414976 · Data updated 2026-11-12
This grant funds an Administrative Core that helps coordinate, manage, and share MGNet’s myasthenia gravis research work with patients and partners.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 1, 2019 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $330,243 |
| NIH project number | 5U54NS115054-07 |
| Project ID | NIH-11414976 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are individuals with myasthenia gravis who may engage with MGNet through trials, registries, or collaboration activities.
✕Less likely to help
Patients not directly involved in MGNet activities or in sites outside the network may see little direct benefit.
What this research studies
The Administrative Core at MGNet provides essential oversight, budgeting, contract management, regulatory support, and data governance to keep MGNet research moving smoothly. It aims to speed site activation, ensure NIH-compliant processes, and maintain data quality across studies. It also coordinates scientific collaboration, communication with patient groups, and support for pilot studies and career development within the network.
Why it matters
Potential benefit: Better organization and data practices can speed up future MG-related research and improve patient access to study opportunities.
How similar studies have gone: Administrative cores in multi-site networks have successfully streamlined coordination and data sharing in rare-disease research.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Kaminski, Henry J — George Washington University
- Study coordinator: Kaminski, Henry J
Related research
Other NIH-funded projects on the same topics.
-
HLA-F and KIR3DS1: unlocking NK cell help to control HIV
A short, patient-friendly look at how a specific immune interaction might help the body control HIV and reduce long-term health problems.
-
Emerging therapies for rare maternal mitochondrial diseases with shared causes
A basket clinical trial will test new drug candidates for two ultra-rare mitochondrial diseases (MELAS and LHON-Plus) that share the same underlying energy-making problem in people who could be affected.
-
Anti-cancer vaccine for liver fluke infection and bile duct cancer
A vaccine approach aims to stop liver fluke interactions with the human bile ducts to prevent bile duct cancer in regions where the parasite is common.
-
Anti-cancer vaccine targeting the host-parasite interface during liver fluke infection
A vaccine approach aims to block how a liver fluke parasite communicates with the human liver to prevent bile duct cancer in people in Southeast Asia.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
-
Ultrasensitive antibody-detection method to screen HIV-bNAbs
A new, ultra-sensitive test will help identify which broadly neutralizing antibodies can best block HIV-1 in people, by quickly checking how well these antibodies interact with the virus in patient-derived samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.